IMMUNOSCAPE
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution. The company’s Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information. This technology has been utilized across multiple therapeutic areas, especially in oncology and infectious disease, both to better understand immunotherapy safety and efficacy and to identify drug targets.
IMMUNOSCAPE
Industry:
Biotechnology Life Science Medical
Founded:
2016-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.immunoscape.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
28.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Advisors List
Current Employees Featured
Founder
Investors List
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - ImmunoScape
EDBI
EDBI investment in Venture Round - ImmunoScape
Anzu Partners
Anzu Partners investment in Venture Round - ImmunoScape
Anzu Partners
Anzu Partners investment in Venture Round - ImmunoScape
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - ImmunoScape
NPR Holdings
NPR Holdings investment in Venture Round - ImmunoScape
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Seed Round - ImmunoScape
Key Employee Changes
| Date | New article |
|---|---|
| 2021-02-23 | ImmunoScape Announces Chief Business Officer to Lead U.S. Expansion |
Official Site Inspections
http://www.immunoscape.com Semrush global rank: 4.87 M Semrush visits lastest month: 1.81 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ImmunoScape"
About Us - ImmunoScape
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. ... driving M&A activity and …See details»
ImmunoScape - Crunchbase Company Profile & Funding
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high …See details»
ImmunoScape discover & develop novel …
We discover and develop a diverse, risk-balanced portfolio of novel TCRs against solid tumors leveraging our Deep Immunomics and Machine Learning platforms. In combination …See details»
ImmunoScape - LinkedIn
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology.See details»
ImmunoScape 2025 Company Profile: Valuation, …
ImmunoScape General Information Description. Developer of immune profiling system and analytical tools designed to support immunotherapy clinical …See details»
Immunoscape, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Immunoscape, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
ImmunoScape - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
ImmunoScape - Products, Competitors, Financials, Employees ...
ImmunoScape focuses on the discovery and development of TCR-based therapeutics in the field of oncology. Use the CB Insights Platform to explore ImmunoScape's full profile. ... About …See details»
immunoSCAPE Company Profile - Office Locations, Competitors, …
ImmunoSCAPE is a company that supports the immunotherapy clinical development by measuring treatment and outcome-associated changes in antigen-specific T cells and patient …See details»
immunoSCAPE - VentureRadar
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. Our proprietary Deep …See details»
ImmunoScape - Crunchbase
Organization. ImmunoScape . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies …See details»
ImmunoScape - Work in biotech
ImmunoScape is discovering and developing next-generation T-cell receptor (TCR) cell therapies to treat cancer. Using their Deep Immunomics and Machine Learning platform, ImmunoScape …See details»
ImmunoScape - Overview, News & Similar companies - ZoomInfo
Mar 19, 2024 Who is ImmunoScape. ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human …See details»
Revolutionizing Immunology With ImmunoScape’s Deep …
Aug 16, 2021 Today, ImmunoScape has grown from a close-knit team of five, to 30 dedicated members across Singapore and San Diego. While the platform addresses many barriers in …See details»
ImmunoScape Appoints Systems Immunology and Computational …
Dec 12, 2023 ImmunoScape is a biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company’s …See details»
ImmunoScape Company Overview, Contact Details & Competitors …
Strategic Partnerships ImmunoScape has partnered with the Experimental Drug Development Centre and MiNK Therapeutics, indicating potential collaboration opportunities for joint …See details»
Our Science - ImmunoScape
TargetScape® is ImmunoScape’s proprietary high-throughput screening platform for rapidly identifying and profiling tumor antigen-reactive T cells in blood and tissue samples at the …See details»
ImmunoScape - Tech Stack, Apps, Patents & Trademarks
Feb 9, 2025 The intellectual property of ImmunoScape includes 5 registered patents primarily in the ' Organic Chemistry ' category, according to IPqwery. Additionally, ImmunoScape has …See details»
ImmunoScape Expands its Executive and Scientific Teams to …
Jun 29, 2021 ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely …See details»
News & resources - ImmunoScape
ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scientific Advisory Board Expertise from award-winning computational... A behind the …See details»